Ibrutinib dose intensity in high‐risk chronic lymphocytic leukemia. Issue 5 (1st June 2022)

• Record Type: Journal Article
• Authors: Forestieri, Gabriela; Terzi di Bergamo, Lodovico; Deodato, Marina; Frustaci, Anna Maria; Moia, Riccardo; Deambrogi, Clara; Rasi, Silvia; Autore, Francesco; Merli, Michele; Mattarucchi, Roberta; Fahrni, Gaby; Scarfo', Lydia; Gussetti, Daniela; Bulian, Pietro; Zanatta, Annagiulia; Spina, Valeria; Bruscaggin, Alessio; Pini, Katia; Piffaretti, Deborah; Pirosa, Maria Cristina; Salehi, Matin; Marques de Almeida, Joyce; Passweg, Jakob; Cavalli, Franco; Zucca, Emanuele; Gerber, Bernhard; Stussi, Georg; Gattei, Valter; Ghia, Paolo; Gregor, Michael; Passamonti, Francesco; Laurenti, Luca; Gaidano, Gianluca; Tedeschi, Alessandra; Rossi, Davide; Condoluci, Adalgisa;
• Is Part Of: Hematological oncology. Volume 40:Issue 5(2022)
• Page Start: 1100
• Page End: 1104
• Publication Date: 2022-06-01
• Subjects: chronic lymphocytic leukemia -- dose intensity -- ibrutinib; Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.3032
• Languages: English
• ISSNs: 0278-0232